Advertisement

Ads Placeholder
Loading...

Newron Pharmaceuticals S.p.A.

NWPHF•PNK
Healthcare
Biotechnology
$20.00
$8.00(66.67%)
U.S. Market opens in 3h 37m

Newron Pharmaceuticals S.p.A. (NWPHF) Stock Overview

Explore Newron Pharmaceuticals S.p.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap399.3M
P/E Ratio13.45
EPS (TTM)N/A
ROE16.69%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

NWPHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Newron Pharmaceuticals S.p.A. (NWPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.45 and a market capitalization of 399.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
221.54%
5-Year Change
221.54%
All-Time (Max) Change
221.54%

Contact Information

https://www.newron.com
39 02 610 3461
Via Antonio Meucci 3, Bresso, MI, 20091

Company Facts

220 Employees
IPO DateAug 30, 2017
CountryIT

Frequently Asked Questions